341 related articles for article (PubMed ID: 24509160)
1. Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure.
Liu P; Zhang M; Shoeb M; Hogan D; Tang L; Syed MF; Wang CZ; Campbell GA; Ansari NH
Free Radic Biol Med; 2014 Apr; 69():289-99. PubMed ID: 24509160
[TBL] [Abstract][Full Text] [Related]
2. Assessment of methylsulfonylmethane as a permeability enhancer for regional EDTA chelation therapy.
Zhang M; Wong IG; Gin JB; Ansari NH
Drug Deliv; 2009 Jul; 16(5):243-8. PubMed ID: 19538004
[TBL] [Abstract][Full Text] [Related]
3. Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract.
Zhang M; Shoeb M; Liu P; Xiao T; Hogan D; Wong IG; Campbell GA; Ansari NH
J Toxicol Environ Health A; 2011; 74(6):380-91. PubMed ID: 21271438
[TBL] [Abstract][Full Text] [Related]
4. Topically applied metal chelator reduces thermal injury progression in a rat model of brass comb burn.
Wang CZ; Ayadi AE; Goswamy J; Finnerty CC; Mifflin R; Sousse L; Enkhbaatar P; Papaconstantinou J; Herndon DN; Ansari NH
Burns; 2015 Dec; 41(8):1775-1787. PubMed ID: 26392023
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma.
Cui QN; Bargoud AR; Ross AG; Song Y; Dunaief JL
Exp Eye Res; 2020 Apr; 193():107961. PubMed ID: 32045598
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical application of methylsulfonylmethane (MSM), EDTA on pitting edema and oxidative stress in a double blind, placebo-controlled study.
Tripathi R; Gupta S; Rai S; Mittal PC
Cell Mol Biol (Noisy-le-grand); 2011 Feb; 57(1):62-9. PubMed ID: 21366964
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.
Neufeld AH; Sawada A; Becker B
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9944-8. PubMed ID: 10449799
[TBL] [Abstract][Full Text] [Related]
8. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
10. Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model.
Steinhart MR; Cone FE; Nguyen C; Nguyen TD; Pease ME; Puk O; Graw J; Oglesby EN; Quigley HA
Mol Vis; 2012; 18():1093-106. PubMed ID: 22701298
[TBL] [Abstract][Full Text] [Related]
11. Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma.
Chan KC; Yu Y; Ng SH; Mak HK; Yip YWY; van der Merwe Y; Ren T; Yung JSY; Biswas S; Cao X; Chau Y; Leung CKS
Acta Biomater; 2019 Aug; 94():219-231. PubMed ID: 31176841
[TBL] [Abstract][Full Text] [Related]
12. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
Thanos S; Naskar R
Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
14. The use of cyclodialysis to limit exposure to elevated intraocular pressure in rat glaucoma models.
Johnson EC; Cepurna WO; Jia L; Morrison JC
Exp Eye Res; 2006 Jul; 83(1):51-60. PubMed ID: 16530758
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration.
Reinhard J; Wiemann S; Joachim SC; Palmhof M; Woestmann J; Denecke B; Wang Y; Downey GP; Faissner A
Mol Neurobiol; 2019 Jun; 56(6):4322-4345. PubMed ID: 30315478
[TBL] [Abstract][Full Text] [Related]
17. Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury.
Johnson EC; Cepurna WO; Choi D; Choe TE; Morrison JC
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):412-9. PubMed ID: 25525172
[TBL] [Abstract][Full Text] [Related]
18. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
Morrison JC; Nylander KB; Lauer AK; Cepurna WO; Johnson E
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):526-31. PubMed ID: 9501862
[TBL] [Abstract][Full Text] [Related]
19. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.
Liu H; Anders F; Thanos S; Mann C; Liu A; Grus FH; Pfeiffer N; Prokosch-Willing V
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5129-5141. PubMed ID: 28986598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
